Literature DB >> 20656705

Headache characteristics and chronification of migraine and tension-type headache: A population-based study.

Sait Ashina1, Ann Lyngberg, Rigmor Jensen.   

Abstract

Migraine and tension-type headache (TTH) can increase in frequency and transform from episodic to chronic forms. The process of transformation of these primary headaches is complex and involves multiple risk factors. In this cross-sectional and longitudinal population study, we aimed to investigate the relation of clinical characteristics of primary headaches to poor outcome: new-onset or persistent chronic headache (> or =180 days/year). Individuals who had migraine + / - TTH and those who had pure TTH were studied separately. Of 740 individuals who entered this study in 1989, 673 were eligible for follow-up in 2001, and a total of 549 individuals participated in the follow-up study. At baseline in 1989, no difference was found between episodic and chronic migraine headache ( + / - TTH). Duration of headache episodes >72 hours (p = .002) was associated with pure chronic TTH at baseline in 1989 whereas aggravation of headache by physical activity (p = .045) was associated with pure frequent episodic TTH. Of 64 subjects with migraine + / - TTH, 12 had a poor outcome in 2001. For pure TTH, of 116 subjects at baseline, 11 had a poor outcome in 2001. Using multivariate logistic regression analysis with adjustment for medication overuse and use of preventive medications, poor outcome of migraine + / - TTH tended to be associated with a baseline pulsating quality and severe intensity of migraine, photophobia and phonophobia, as well as longer duration of an individual headache attack. For pure TTH, unilateral headache, nausea and individual headache attack duration greater than 72 hours was associated with poor outcome. Pooled data univariate analysis revealed that nausea, daily use of acute headache medications, use of headache preventive medications and coexistent headaches were significant predictors of chronic headache in 2001(p<.05). In conclusion, our study demonstrates that certain clinical characteristics of headaches are associated with poor outcome but alone may not predict the chronification of migraine or TTH.

Entities:  

Mesh:

Year:  2010        PMID: 20656705     DOI: 10.1177/0333102409357958

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  14 in total

Review 1.  Controversy over the classification of medication-overuse headache.

Authors:  Maurice B Vincent
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients.

Authors:  Chris Della Vedova; Stuart Cathcart; Alan Dohnalek; Vanessa Lee; Mark R Hutchinson; Maarten A Immink; John Hayball
Journal:  Pain Res Manag       Date:  2013-08-16       Impact factor: 3.037

Review 3.  Risk factors of chronic daily headache or chronic migraine.

Authors:  Soo-Jin Cho; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2015-01

Review 4.  Chronic migraine: epidemiology and disease burden.

Authors:  Aubrey N Manack; Dawn C Buse; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 5.  Neurobiology of migraine progression.

Authors:  Wanakorn Rattanawong; Alan Rapoport; Anan Srikiatkhachorn
Journal:  Neurobiol Pain       Date:  2022-06-09

Review 6.  Epidemiology and cultural differences in tension-type headache.

Authors:  Kristen Sahler
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 7.  The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update.

Authors:  Christina Sun-Edelstein; Alan M Rapoport; Wanakorn Rattanawong; Anan Srikiatkhachorn
Journal:  CNS Drugs       Date:  2021-05-17       Impact factor: 5.749

Review 8.  Photophobia in headache disorders: characteristics and potential mechanisms.

Authors:  Yajuan Wang; Shaoyang Wang; Tao Qiu; Zheman Xiao
Journal:  J Neurol       Date:  2022-03-23       Impact factor: 6.682

Review 9.  Targeting TRP channels for novel migraine therapeutics.

Authors:  Gregory Dussor; J Yan; Jennifer Y Xie; Michael H Ossipov; David W Dodick; Frank Porreca
Journal:  ACS Chem Neurosci       Date:  2014-08-29       Impact factor: 4.418

10.  Depression and risk of transformation of episodic to chronic migraine.

Authors:  Sait Ashina; Daniel Serrano; Richard B Lipton; Morris Maizels; Aubrey N Manack; Catherine C Turkel; Michael L Reed; Dawn C Buse
Journal:  J Headache Pain       Date:  2012-09-25       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.